title: Regression of cutaneous squamous cell carcinoma in a patient with chronic myeloid leukaemia on imatinib mesylate treatment.
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Kawakami
authors.forename: Koichiro
authors.initials: K
authors.lastname: Nakamura
authors.forename: Akiko
authors.initials: A
authors.lastname: Nishibu
authors.forename: Hirokatsu
authors.initials: H
authors.lastname: Yanagihori
authors.forename: Hideo
authors.initials: H
authors.lastname: Kimura
authors.forename: Toshiyuki
authors.initials: T
authors.lastname: Yamamoto
mesh_terms: D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D002294:Carcinoma, Squamous Cell / Q000473:pathology*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D009378:Neoplasms, Multiple Primary; D010879:Piperazines / Q000627:therapeutic use*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011743:Pyrimidines / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000473:pathology*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D011505:Protein-Tyrosine Kinases